Chernobyl disaster anniversary puts spotlight on region's healthcare needs:
This article was originally published in Clinica
Executive Summary
Amid a flurry of new data and recommended healthcare activities, today's 20th anniversary of the Chernobyl nuclear disaster of 1986 was marked by calls for an extensive, internationally-funded and independent programme of assessments of the health effects of the accident. The expectation is that such assessments might spur further measures to identify and act upon the affected region's healthcare service and investment needs.
You may also be interested in...
Simplified Clinical Trial Transparency Rules To Go Live In The EU In June
A new version of the EU Clinical Trials Information System’s public portal will integrate the functionalities of the streamlined transparency rules.
Top-Selling Drugs 2023: Pharma’s $60bn COVID-19 Cliff
Pfizer/BioNTech’s COVID-19 vaccine Comirnaty toppled after recording the highest ever annual sales for a pharmaceutical in 2022, while Novo Nordisk’s Ozempic climbed rapidly. But Merck & Co’s immuno-oncology blockbuster Keytruda was secure in the number one spot in 2023 as COVID-19 receded.
Changes To EU Pharma Reform: More Questions Than Answers?
In the first of a series of articles on the future direction of the EU pharmaceutical reform proposals, the Pink Sheet looks at the new uncertainties created for the drug industry after the European Parliament voted through a series of amendments in the area of regulatory data protection.